129 related articles for article (PubMed ID: 35260348)
1. Hereditary Cancer Gene Variants in Hispanic Men With a Personal or Family History of Prostate Cancer.
Ramamurthy C; Stutz EW; Goros M; Gelfond J; Johnson-Pais TL; Thompson IM; Leach RJ; Liss MA
Clin Genitourin Cancer; 2022 Jun; 20(3):237-243. PubMed ID: 35260348
[TBL] [Abstract][Full Text] [Related]
2. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN
Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
Brady L; Newcomb LF; Zhu K; Zheng Y; Boyer H; Sarkar N; McKenney JK; Brooks JD; Carroll PR; Dash A; Ellis WJ; Filson CP; Gleave ME; Liss MA; Martin F; Morgan TM; Thompson IM; Wagner AA; Pritchard CC; Lin DW; Nelson PS
Cancer Med; 2022 Nov; 11(22):4332-4340. PubMed ID: 35467778
[TBL] [Abstract][Full Text] [Related]
5. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
6. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer.
Isaacsson Velho P; Silberstein JL; Markowski MC; Luo J; Lotan TL; Isaacs WB; Antonarakis ES
Prostate; 2018 Apr; 78(5):401-407. PubMed ID: 29368341
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Nicolosi P; Ledet E; Yang S; Michalski S; Freschi B; O'Leary E; Esplin ED; Nussbaum RL; Sartor O
JAMA Oncol; 2019 Apr; 5(4):523-528. PubMed ID: 30730552
[TBL] [Abstract][Full Text] [Related]
8. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
9. Germline pathogenic variants in unselected Korean men with prostate cancer.
So MK; Ahn HK; Huh J; Kim KH
Investig Clin Urol; 2022 May; 63(3):294-300. PubMed ID: 35534218
[TBL] [Abstract][Full Text] [Related]
10. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Pritchard CC; Mateo J; Walsh MF; De Sarkar N; Abida W; Beltran H; Garofalo A; Gulati R; Carreira S; Eeles R; Elemento O; Rubin MA; Robinson D; Lonigro R; Hussain M; Chinnaiyan A; Vinson J; Filipenko J; Garraway L; Taplin ME; AlDubayan S; Han GC; Beightol M; Morrissey C; Nghiem B; Cheng HH; Montgomery B; Walsh T; Casadei S; Berger M; Zhang L; Zehir A; Vijai J; Scher HI; Sawyers C; Schultz N; Kantoff PW; Solit D; Robson M; Van Allen EM; Offit K; de Bono J; Nelson PS
N Engl J Med; 2016 Aug; 375(5):443-53. PubMed ID: 27433846
[TBL] [Abstract][Full Text] [Related]
11. Commentary on "Inherited DNA-repair gene mutations in men with metastatic prostate cancer". Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016;375(5):443-53.
Freedland SJ; Aronson WJ
Urol Oncol; 2017 Aug; 35(8):536-537. PubMed ID: 28623070
[TBL] [Abstract][Full Text] [Related]
12. Commentary on: "Inherited DNA-repair gene mutations in men with metastatic prostate cancer." Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, Garofalo A, Gulati R, Carreira S, Eeles R, Elemento O, Rubin MA, Robinson D, Lonigro R, Hussain M, Chinnaiyan A, Vinson J, Filipenko J, Garraway L, Taplin ME, AlDubayan S, Han GC, Beightol M, Morrissey C, Nghiem B, Cheng HH, Montgomery B, Walsh T, Casadei S, Berger M, Zhang L, Zehir A, Vijai J, Scher HI, Sawyers C, Schultz N, Kantoff PW, Solit D, Robson M, Van Allen EM, Offit K, de Bono J, Nelson PS. N Engl J Med. 2016 Aug 4;375(5):443-53.
Lee BH
Urol Oncol; 2017 Sep; 35(9):575-576. PubMed ID: 28789927
[TBL] [Abstract][Full Text] [Related]
13. Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate Cancer.
Chávarri-Guerra Y; Bourlon MT; Rodríguez-Olivares JL; Orozco L; Bazua D; Rodríguez-Faure A; Alcalde-Castro MJ; Castro E; Castillo D; Herzog J; Weitzel J
Clin Genitourin Cancer; 2023 Oct; 21(5):569-573. PubMed ID: 37380563
[TBL] [Abstract][Full Text] [Related]
14. Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer.
Gheybi K; Jiang J; Mutambirwa SBA; Soh PXY; Kote-Jarai Z; Jaratlerdsiri W; Eeles RA; Bornman MSR; Hayes VM
J Natl Compr Canc Netw; 2023 Mar; 21(3):289-296.e3. PubMed ID: 36898365
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing hereditary cancer predisposition in men with prostate cancer.
Pritzlaff M; Tian Y; Reineke P; Stuenkel AJ; Allen K; Gutierrez S; Jackson M; Dolinsky JS; LaDuca H; Xu J; Black MH; Helfand BT
Genet Med; 2020 Sep; 22(9):1517-1523. PubMed ID: 32439974
[TBL] [Abstract][Full Text] [Related]
16. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.
Cheng HH; Sokolova AO; Gulati R; Bowen D; Knerr SA; Klemfuss N; Grivas P; Hsieh A; Lee JK; Schweizer MT; Yezefski T; Zhou A; Yu EY; Nelson PS; Montgomery B
JCO Precis Oncol; 2023 Jan; 7():e2200104. PubMed ID: 36623239
[TBL] [Abstract][Full Text] [Related]
17. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
AlDubayan SH; Conway JR; Camp SY; Witkowski L; Kofman E; Reardon B; Han S; Moore N; Elmarakeby H; Salari K; Choudhry H; Al-Rubaish AM; Al-Sulaiman AA; Al-Ali AK; Taylor-Weiner A; Van Allen EM
JAMA; 2020 Nov; 324(19):1957-1969. PubMed ID: 33201204
[TBL] [Abstract][Full Text] [Related]
18. Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.
Antonarakis ES; Lu C; Luber B; Liang C; Wang H; Chen Y; Silberstein JL; Piana D; Lai Z; Chen Y; Isaacs WB; Luo J
Eur Urol; 2018 Aug; 74(2):218-225. PubMed ID: 29439820
[TBL] [Abstract][Full Text] [Related]
19. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
Das S; Salami SS; Spratt DE; Kaffenberger SD; Jacobs MF; Morgan TM
J Urol; 2019 Aug; 202(2):223-230. PubMed ID: 30730411
[TBL] [Abstract][Full Text] [Related]
20. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O
Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
